Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
In a financial emergency, knowing what to do is crucial. Discover effective steps to take to manage your situation promptly.
15,764 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A high-profile insider sale can spark questions about a company’s future. This article breaks down the HeartFlow CEO'...
Bank of America named two new leaders to oversee digital assets and AI transformation, signaling a strategic push to ...
A Paychex insider recently moved tens of thousands of shares, prompting questions about the stock’s trajectory. This ...
New reports say Lagarde is weighing an earlier departure, which could derail the ECB's digital euro plan and MiCA rol...
Retirement income from Social Security isn’t a one-size-fits-all number. This deep dive explains what the average ret...
As markets ride a strong rally tied to policy expectations, a shift could come fast. This in-depth guide explains how...
Institutional players are accelerating tokenization and on-chain strategies, even as many traditional investors lag b...
A Friday deadline intensifies a clash between Anthropic and the Pentagon over how its Claude AI models may be used by...
The Pentagon has begun using low-cost drones modeled after Iran’s Shahed systems in recent strikes, raising questions...
The Intercontinental Exchange, parent of the NYSE, is purchasing a minority stake in OKX, valuing the crypto exchange...
Joby Aviation has faced a rough start to 2026 after a big rally in 2025. This guide explains whether the stock is rig...